Citadel Advisors’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $34 | Hold |
|
|||||
|
2024
Q4 | $26 | Buy |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $3.47K | Buy |
|
|||||
|
2023
Q4 | $1.52K | Sell |
|
|||||
|
2023
Q3 | $447K | Buy |
|
|||||
|
2023
Q2 | $200K | Sell |
|
|||||
|
2023
Q1 | $3M | Buy |
|
|||||
|
2022
Q4 | $14.7K | Sell |
|
|||||
|
2022
Q3 | $216K | Sell |
|
|||||
|
2022
Q2 | $563K | Sell |
|
|||||
|
2022
Q1 | $1.69M | Sell |
|
|||||
|
2021
Q4 | $3.3M | Buy |
|
|||||
|
2021
Q3 | $663K | Sell |
|
|||||
|
2021
Q2 | $6.66M | Sell |
|
|||||
|
2021
Q1 | $7M | Buy |
|
|||||
|
2020
Q4 | $7.09M | Buy |
|
|||||
|
2020
Q3 | $2.05M | Buy |
|
|||||
|
2020
Q2 | $154K | Sell |
|
|||||
|
2020
Q1 | $161K | Sell |
|
|||||
|
2019
Q4 | $168K | Buy |
|
|||||
|
2019
Q3 | $72K | Sell |
|
|||||
|
2019
Q2 | $212K | Buy |
|
|||||
|
2019
Q1 | $109K | Sell |
|
|||||
|
2018
Q4 | $200K | Buy |
|
|||||
|
2018
Q3 | $239K | Buy |
|
|||||
|
2018
Q2 | $183K | Sell |
|
|||||
|
2018
Q1 | $1M | Sell |
|
|||||
|
2017
Q4 | $1.4M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $455K | Buy |
|
|||||
|
2017
Q1 | $233K | Buy |
|
|||||
|
2016
Q4 | $117K | Sell |
|
|||||
|
2016
Q3 | $1.16M | Buy |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $8.02M | Buy |
|